LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Surgical NAV Firm Crosses 200,000 Arthroplasties Milestone
Large Joints and Extremities

Surgical NAV Firm Crosses 200,000 Arthroplasties Milestone

October 18, 2021 2 min read Premium comments

Advertisement

#orthalign#kneealign#lantern

OrthAlign, Inc., based in Aliso Viejo, California, which has developed, literally, a hand-held computerized surgical navigation device, announced that it had officially crossed the 200,000 joint replacement surgery milestone around the globe.

Because, in contrast to other systems, this software-driven, surgical navigation computer is hand-held, affordable, and user-friendly, the company’s marketing tag line is: “Any surgeon OR Any time”.

One other attribute of the hand-held NAV computer…. it’s a single-use device.  Also, cheaper.

Eric Timko, chairman and CEO of OrthAlign Inc., was justifiably proud of such a milestone and expanded on the market for such powerful, versatile and convenient surgical tools to OTW, “The market is evolving, and technology in every case will be the standard of care. The need for a clinically proven, efficient, and cost-effective tools that emphasizes clinical value will play a big role as the market reacts to the impact of Covid on patient backlogs and the accelerating shift of procedures to the ambulatory surgery center. Our experience with over 200K cases and a wealth of clinical data has established our position as the leader in handheld navigation, and we’re excited for the next 200K.”

“Timing could not be better as we launch our new flagship technology, Lantern®. Surgeons, hospitals, and ambulatory surgery centers will appreciate the positive impact Lantern® will have on their patients, staff, and bottom line. I am very proud of our team and our commitment to bringing a new product to market now, and not letting Covid get in the way of innovating and making empowering technologies accessible to all.”

OrthAlign offers up patient-tailored alignment and can be used across implant platforms. The company has aimed to streamline workflows to “reduce OR times and support multiple ORs concurrently without the investment, equipment, or pre-operative imaging required by many computer-assisted surgical systems. The technology is optimized for the ASC with only one instrument tray, one navigation unit for all applications, and no storage requirements or service plans.”

“OrthAlign has given me accuracy and reproducibility,” said Dr. Rafael Sierra, orthopedic surgeon in Rochester, Minnesota. “My first introduction to OrthAlign was a tough case with hardware in the femur, and I wanted to see if I could avoid taking the hardware out of a young patient. OrthAlign was the perfect instrument for that situation. After that experience, I was very excited about its use and expanded it into my other knee replacements. When performing anatomic alignment, it is very challenging with manual instrumentation, to determine the exact degree of a slightly varus tibial cut. You want consistent precision, and that’s what OrthAlign gives me.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy